Type II alveolar cells, a major cell type infected by SARS-CoV-2, possess unique immunologic properties and appear to play a role in improving the outcome of respiratory viral infections.

CHOP researchers have found ADHD medications may lower suicide risk in children with hyperactivity, oppositional defiance and other behavioral disorders.

As part of a longstanding partnership with the United Arab Emirates (UAE) Ministry of Health and Prevention (MOHAP), CHOP showcased innovative diagnostic tools to assess head trauma in real time as an athlete is competing and experiencing injury in the MOHAP booth at the annual Arab Health Exhibition and Congress.

Pattern of risky driving practices associated with impulsivity, including speeding and running red lights.

CHOP is the only center to capture standardized clinical data from ongoing patient care.

CHOP researchers have developed a proof-of-concept treatment for blood disorders like sickle cell disease that elevates both fetal and adult hemoglobin.

The new search engine, called PhenCards, can help researchers, clinicians, and genetic counselors make more informed clinical decisions.

New findings set stage for future targeted therapies for patients with 22q11.2 deletion syndrome, who are 25 times more likely to develop schizophrenia.

A dozen patients have clinical features linked to the genetic variants, and preclinical models reveal more about how they affect normal function.

CHOP researchers found a link between depressive symptoms and pandemic-related income loss and financial strain, independent of anxiety.